Anticipated Shortage

VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP

HIKMA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP in Canada?

A shortage of VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP 500MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 9, 2026), but it has not started yet.

Why is VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP not available?

The reason the manufacturer reported: Demand increase for the drug.

When will VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP be available again?

The manufacturer's estimated resolution date is January 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file2 products · 1 same form & route

Expected resolution~3 months remaining (estimate)

Affected strength500MG

Report last updated2026-10-09

Checked by MedShort2026-10-17

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP

STERIMAX INC

500MG · DIN 02342855

Same strengthSame dosage formNot enough data to compareNo current shortage

Compare these two →

VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP

FRESENIUS KABI CANADA LTD

5G · DIN 02139243

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2027-01-31

~3 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02543974

Strength

500MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

VANCOMYCIN

Tier

Unrated

Last Updated

2026-10-09

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from HIKMA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02304341

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02459906

ATROPINE INJECTION BP

0.6MG · DIN 02432196

ATROPINE INJECTION BP

0.4MG · DIN 02432188

AZACITIDINE FOR INJECTION

100MG · DIN 02507668

BACLOFEN INJECTION

0.05MG · DIN 02457059